Assessing T-Cell Profile Shifts via IL-23 Inhibition by Guselkumab on Psoriasis.
RNA-seq (gene expression) · human · 72 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 72 samples: 72 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Assessing T-Cell Profile Shifts through IL-23 Inhibition by Guselkumab on PsoriasisJID innovations : skin science from molecules to population health · 2026
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE290870_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1230558 and SRA study SRP567365. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 72 sample titles: 72 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8824382 G-G_Case1_0W
- GSM8824383 G-G_Case1_4W
- GSM8824384 G-G_Case1_12W
- GSM8824385 G-G_Case2_0W
- GSM8824386 G-G_Case2_4W
- GSM8824387 G-G_Case2_12W
- GSM8824388 G-G_Case3_0W
- GSM8824389 G-G_Case3_4W
- GSM8824390 G-G_Case3_12W
- GSM8824391 G-G_Case4_0W
- GSM8824392 G-G_Case4_4W
- GSM8824393 G-G_Case4_12W
- GSM8824394 G-G_Case5_0W
- GSM8824395 G-G_Case5_4W
- GSM8824396 G-G_Case5_12W
- GSM8824397 G-G_Case6_0W
- GSM8824398 G-G_Case6_4W
- GSM8824399 G-G_Case6_12W
- GSM8824400 G-G_Case7_0W
- GSM8824401 G-G_Case7_4W
- GSM8824402 G-G_Case7_12W
- GSM8824403 G-G_Case10_0W
- GSM8824404 G-G_Case10_4W
- GSM8824405 G-G_Case10_12W
- GSM8824406 G-G_Case11_0W
- GSM8824407 G-G_Case11_4W
- GSM8824408 G-G_Case11_12W
- GSM8824409 G-G_Case12_0W
- GSM8824410 G-G_Case12_4W
- GSM8824411 G-G_Case12_12W
- GSM8824412 G-G_Case13_0W
- GSM8824413 G-G_Case13_4W
- GSM8824414 G-G_Case13_12W
- GSM8824415 G-G_Case14_0W
- GSM8824416 G-G_Case14_4W
- GSM8824417 G-G_Case14_12W
- GSM8824418 G-G_Case15_0W
- GSM8824419 G-G_Case15_4W
- GSM8824420 G-G_Case15_12W
- GSM8824421 G-G_Case16_0W
+ 32 more — browse all 72 samples with per-sample file links →
- GSE278330 Systemic IL-23 blockade downregulates IL-23 receptor-expressing Type 17 T-cell subsets and upregulates regulatory gene expression in myeloid cells in human psoriasis skin 63 samples shares il-23, psoriasis, t-cell
- GSE328285 Inhibition of Salt-Inducible Kinases 2 and 3 reduces inflammatory signature in Psoriasis 10 samples shares inhibition, psoriasis
- GSE270795 IL-23 tunes inflammatory functions of human MAIT cells 27 samples shares il-23
- GSE254732 Inhibition of PCSK9 with evolocumab modulates lipoproteins and monocyte activation in high-risk ASCVD subjects 215 samples shares inhibition
- GSE275078 In vitro drug screening of RAF/MEK/ERK Inhibitors in combination with Autophagy inhibition in the context of two PDA Cell Lines 136 samples shares inhibition
- GSE274142 Single-Cell RNA Sequencing Identifies Molecular Biomarkers Predicting Late Progression to CDK4/6 Inhibition in Patients with HR+/HER2- Metastatic Breast Cancer 89 samples shares inhibition
- GSE266219 Clinical and Immunological Responses to Combined JAK Inhibition and PD-1 immunotherapy for Lung Cancer Patients 79 samples shares inhibition
- GSE304126 CDK8 inhibition sequesters Med1 at EWS-FLI enhancers [RNA-Seq] 68 samples shares inhibition
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.